Case Control Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 14, 2021; 27(2): 162-175
Published online Jan 14, 2021. doi: 10.3748/wjg.v27.i2.162
Figure 6
Figure 6 Evaluation of the usefulness of the 10-7G value for pathologic diagnosis of ulcerative colitis compared to C-reactive protein and leucine-rich alpha-2 glycoprotein. A-C: Analysis of receiver operating characteristic curves for 10-7G value, leucine-rich alpha-2 glycoprotein, and C-reactive protein for differentiation between ulcerative colitis (UC) patients with endoscopic mucosal remission by Mayo endoscopic subscore (MES). AUC: Area under the curve; MES: Mayo endoscopic subscore; LRG: Leucine-rich alpha-2 glycoprotein; CRP: C-reactive protein.

  • Citation: Motooka K, Morishita K, Ito N, Shinzaki S, Tashiro T, Nojima S, Shimizu K, Date M, Sakata N, Yamada M, Takamatsu S, Kamada Y, Iijima H, Mizushima T, Morii E, Takehara T, Miyoshi E. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis. World J Gastroenterol 2021; 27(2): 162-175
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i2/162.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i2.162